Broom Colin MD

Track

Insider profile

Performance

Overall performance
1.7
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 28% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -68%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Broom Colin MD's trades of Nabriva Therapeutics PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
42.11
Quantity 63,774 -10.8%
Value US$3,957,848
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-08-04 2022-08-02
S Sale
95,246 -20.3%
230.19
US$3,102,342 		95,246 -20.3% 230.19 US$3,102,342
2020-08-21 2020-08-20
S Sale
63,774 -10.8%
42.11
US$3,957,848 		63,774 -10.8% 42.11 US$3,957,848
2019-09-03 2019-08-30
B Purchase
90,130 +42.3%
66.52
US$4,440,583 		90,130 +42.3% 66.52 US$4,440,583